Protagenic Therapeutics, Inc.new (PTIX) Net Income Attributable to Noncontrolling Interests (2009 - 2026)
Protagenic Therapeutics, Inc.new (PTIX) reported Net Income Attributable to Noncontrolling Interests of $4.83 million for fiscal Q4 2026 (quarter ended Mar 31, 2026), up 118.4% from the prior quarter.
Protagenic Therapeutics, Inc.new (PTIX) Net Income Attributable to Noncontrolling Interests (2009 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Protagenic Therapeutics, Inc.new posted Net Income Attributable to Noncontrolling Interests of $1.04 million.
- By fiscal year, Net Income Attributable to Noncontrolling Interests came in at -$3.62 million in FY2025 and -$1.89 million in FY2024.
- The fiscal Q4 2026 figure ranks as the highest quarterly Net Income Attributable to Noncontrolling Interests in data going back to fiscal Q1 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | - |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 10.00 Mn |
| 10 | Protagenic Therapeutics, Inc.new | 850,797.76 | -4.70 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 4.83 Mn |
| Dec 31, 2025 | 2.21 Mn |
| Dec 31, 2024 | -847,541.00 |
| Dec 31, 2015 | -1,000.00 |
| Sep 30, 2015 | -5,000.00 |
| Mar 31, 2015 | -7,000.00 |
| Dec 31, 2014 | -6,000.00 |
| Sep 30, 2014 | -7,000.00 |
| Jun 30, 2014 | -14,000.00 |
| Mar 31, 2014 | -11,000.00 |
| Dec 31, 2013 | -12,000.00 |
| Sep 30, 2013 | -12,000.00 |
| Jun 30, 2009 | 46,000.00 |
| Mar 31, 2009 | -18,000.00 |
Protagenic Therapeutics, Inc.new Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=PTIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();